Solving the Challenges of Hematalogic Malignancies through Translational Research
Friday, December 5, 2008
San Francisco, California
The Moscone Center: Exhibit Level Room 104 Symposium
Friday, December 5, 2008
12:30 pm
Lunch: Exhibit Level Room 102/103
1:30 pm
Adjourn to symposium:
Exhibit Level Room 104
1:45 pm
Epigenetics and cancer:
A causal relationship
Jonathan Licht, MD
2:05 pm
Q&A
2:10 pm
Targeting histone deacetylase to reverse the malignant phenotype
Owen O’Connor, MD, PhD
2:30 pm
Q&A
2:35 pm
Novel inhibitors of histone deacetylase and their role in cancer therapy
H. Miles Prince, MD, MRACMA, FRACP, FRCPA
2:55 pm
Q&A
3:00 pm
Targeting tyrosine kinases in hematologic malignancies: Selecting targets and designing therapeutic agents
Francis J. Giles, MB, MD, FRCPI, FRCPath
3:20 pm Q&A
3:25 pm
Novel inhibitors of tyrosine kinases and their expanding roles in hematologic malignancies
Ruben Mesa, MD
3:45 pm
Q&A
3:50 pm
Managing the increasing therapeutic options available for chronic myeloid leukemia
Francis J. Giles, MB, MD, FRCPI, FRCPath
4:10 pm
Q&A
4:15 pm
Adjourn

